The conversation discusses using cyproterone temporarily to reverse hair loss, followed by finasteride to maintain regrowth. Concerns about cyproterone's side effects, such as lowering testosterone and potential health risks, are raised, with alternatives like spironolactone suggested for androgen-related issues.
Pelage secured $120 million for PP405, a non-hormonal topical hair loss treatment, sparking debate on its potential as a breakthrough. Concerns about finasteride's side effects persist, with some suggesting alternatives like topical finasteride or dutasteride.
Oral minoxidil and spironolactone helped restore the hairline but not the scalp behind it. Hairline and temples often respond first to treatment, with mid-scalp and crown following later.
Choosing between good and great hair transplant surgeons, considering factors like wait times, costs, and potential risks of mid-tier clinics. The user is contemplating whether to opt for a reputable clinic in Cancun or save for an elite surgeon.
A user shared progress pictures showing improvement from NW 6 to NW 2 after four months of treatment. They are considering using exosomes to further reverse hair miniaturization.
Chinese researchers have successfully created hair follicles in vitro, potentially offering unlimited hair for transplantation and a cure for hair loss. They plan to test these follicles in vivo on human scalps.
The user diagnosed with DUPA tried treatments like dutasteride, finasteride, RU58841, and minoxidil without success and is considering a hair system. They hope for a future cure, possibly with PP405, and others suggest options like scalp biopsy and SMP.
A user's experience with Pyrilutamide for hair loss, which has been successful in reversing receding hairline when part of their stack with other treatments such as Dutasteride, Minoxidil, and Ketoconazole shampoo.
A user shared their experience with a Long Hair DHI Hair Transplant, receiving 2,750 grafts. They plan to continue using Dutasteride and Topical Minoxidil post-surgery.
Pyrilutimide, a treatment for hair loss; it's effectiveness compared to other treatments such as Finasteride and RU58841; and some users’ experiences with the treatment.
The conversation discusses the potential of Replicel/Shiseido treatment for hair loss, questioning its effectiveness, whether it grows new follicles, and its market release timeline. It also compares Replicel to other competitors like Kyocera/RIKEN/Tsuji.
Minoxidil, dutasteride, and copper peptides are used in a tattooing method for hair regrowth, with some users noting better results compared to oral treatments. Copper peptides are considered to have minimal impact, but the method may reduce side effects.
A new hair loss treatment, pp405, may regrow hair better than finasteride and minoxidil, with potential availability by 2028. However, there is skepticism about its effectiveness and commercialization timeline.
A 22-year-old had a 3,500 graft hair transplant to restore his original hairline and improve density, while using dutasteride and oral minoxidil to manage hair loss. He believes being proactive with medication prevented further loss and allowed for a successful transplant.
Hair regrowth and gender transition using finasteride, estrogen, and spironolactone. Significant hair regrowth and personal transformation were achieved through hormone replacement therapy.
PP405, developed by Pelage Pharmaceuticals, can reactivate dormant hair follicle stem cells and increase hair growth by 20% in eight weeks, unlike minoxidil or finasteride. However, skepticism remains about its effectiveness and availability, with concerns about funding and the timeline for broader access.
A user shared their positive experience with a hair transplant in Turkey, where they received 3500 grafts. They started using finasteride, minoxidil, biotin, and ajuga reptans supplements after one month, and posted progress pictures at 1, 2, and 6 months post-transplant.
The conversation is about considering switching from Fluridil to Pyrilutamide for hair loss treatment. Pyrilutamide is suggested to be more effective, with a recommendation to use the 1% variant twice daily.
A user shared progress pictures one year after a hair transplant with 2,000 grafts on the crown area. They use topical minoxidil and finasteride daily, along with biotin supplements.
The conversation discusses using topical spironolactone for temple hair loss, alongside low-dose minoxidil and possibly PDRN injections, without finasteride or dutasteride. The user is skeptical about the injections due to cost and mild hair loss severity.
A 27-year-old shared progress pictures 4 months after a hair transplant, expressing satisfaction with the results and improved self-esteem. They have been using finasteride for nearly a year and minoxidil for 3 months, with significant reduction in hair loss.
User tried topical finasteride mixed with minoxidil, Nizoral shampoo, oral minoxidil, and FUE hair transplant for hair loss. User asks when it's safe to trim hair after transplant and considers trying RU58841 or pyrilutamide.
A 24-year-old male is considering the "Big 4" treatments (Finasteride, Minoxidil, Ketoconazole shampoo, and Microneedling) or a hair transplant for hair loss. Most users recommend starting with Finasteride and Minoxidil to stabilize hair loss before considering a transplant.
A 35-year-old man shared his hair transplant experience in Tijuana, Mexico, choosing Artline for 5,000 grafts at a lower cost than U.S. clinics. He plans to use topical minoxidil and possibly microneedling for better results.
A user shared their positive experience with a hair transplant at Smile Hair Clinic, using treatments like oral finasteride, minoxidil, and dutasteride. They reported no side effects, significant improvement in hair density, and satisfaction with the results.
A user shared their experience with hair loss, using finasteride and minoxidil, and eventually undergoing a hair transplant of 1800 grafts. They regret not starting finasteride earlier and mention that despite the transplant, their scalp is still visible under strong light.
PP405 is a new hair loss treatment targeting dormant hair follicles, with ongoing trials. Some users consider stopping finasteride and minoxidil to join trials, while others doubt its effectiveness.